359 related articles for article (PubMed ID: 27820834)
1. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
Chen X; Wang Y; Nelson D; Tian S; Mulvey E; Patel B; Conti I; Jaen J; Rollins BJ
PLoS One; 2016; 11(11):e0165595. PubMed ID: 27820834
[TBL] [Abstract][Full Text] [Related]
2. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
Brummer G; Fang W; Smart C; Zinda B; Alissa N; Berkland C; Miller D; Cheng N
Oncogene; 2020 Mar; 39(11):2275-2289. PubMed ID: 31827233
[TBL] [Abstract][Full Text] [Related]
3. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
4. Gas6 Promotes Inflammatory (CCR2
Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
[TBL] [Abstract][Full Text] [Related]
5. CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.
Fang WB; Jokar I; Zou A; Lambert D; Dendukuri P; Cheng N
J Biol Chem; 2012 Oct; 287(43):36593-608. PubMed ID: 22927430
[TBL] [Abstract][Full Text] [Related]
6. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
7. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.
Izhak L; Wildbaum G; Jung S; Stein A; Shaked Y; Karin N
PLoS One; 2012; 7(1):e28305. PubMed ID: 22279523
[TBL] [Abstract][Full Text] [Related]
9. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
Front Immunol; 2022; 13():993444. PubMed ID: 36685592
[TBL] [Abstract][Full Text] [Related]
10. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
[TBL] [Abstract][Full Text] [Related]
11. Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.
Brummer G; Acevedo DS; Hu Q; Portsche M; Fang WB; Yao M; Zinda B; Myers M; Alvarez N; Fields P; Hong Y; Behbod F; Cheng N
Mol Cancer Res; 2018 Feb; 16(2):296-308. PubMed ID: 29133591
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.
Sanford DE; Belt BA; Panni RZ; Mayer A; Deshpande AD; Carpenter D; Mitchem JB; Plambeck-Suess SM; Worley LA; Goetz BD; Wang-Gillam A; Eberlein TJ; Denardo DG; Goedegebuure SP; Linehan DC
Clin Cancer Res; 2013 Jul; 19(13):3404-15. PubMed ID: 23653148
[TBL] [Abstract][Full Text] [Related]
13. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.
Hu WT; Li MQ; Liu W; Jin LP; Li DJ; Zhu XY
Mol Hum Reprod; 2014 Apr; 20(4):358-72. PubMed ID: 24344240
[TBL] [Abstract][Full Text] [Related]
14. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Qian BZ; Li J; Zhang H; Kitamura T; Zhang J; Campion LR; Kaiser EA; Snyder LA; Pollard JW
Nature; 2011 Jun; 475(7355):222-5. PubMed ID: 21654748
[TBL] [Abstract][Full Text] [Related]
15. Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.
Owen JL; Criscitiello MF; Libreros S; Garcia-Areas R; Guthrie K; Torroella-Kouri M; Iragavarapu-Charyulu V
Cell Immunol; 2011; 270(2):172-82. PubMed ID: 21621198
[TBL] [Abstract][Full Text] [Related]
16. Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1.
Wang S; Xu M; Li F; Wang X; Bower KA; Frank JA; Lu Y; Chen G; Zhang Z; Ke Z; Shi X; Luo J
Breast Cancer Res Treat; 2012 Jun; 133(3):1037-48. PubMed ID: 22160640
[TBL] [Abstract][Full Text] [Related]
17. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair.
Lu H; Huang D; Ransohoff RM; Zhou L
FASEB J; 2011 Oct; 25(10):3344-55. PubMed ID: 21697550
[TBL] [Abstract][Full Text] [Related]
18. A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.
Zhang J; Sarkar S; Cua R; Zhou Y; Hader W; Yong VW
Carcinogenesis; 2012 Feb; 33(2):312-9. PubMed ID: 22159219
[TBL] [Abstract][Full Text] [Related]
19. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Auvynet C; Baudesson de Chanville C; Hermand P; Dorgham K; Piesse C; Pouchy C; Carlier L; Poupel L; Barthélémy S; Felouzis V; Lacombe C; Sagan S; Chemtob S; Quiniou C; Salomon B; Deterre P; Sennlaub F; Combadière C
FASEB J; 2016 Jun; 30(6):2370-81. PubMed ID: 26979087
[TBL] [Abstract][Full Text] [Related]
20. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile.
Sierra-Filardi E; Nieto C; Domínguez-Soto A; Barroso R; Sánchez-Mateos P; Puig-Kroger A; López-Bravo M; Joven J; Ardavín C; Rodríguez-Fernández JL; Sánchez-Torres C; Mellado M; Corbí AL
J Immunol; 2014 Apr; 192(8):3858-67. PubMed ID: 24639350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
